"Pfizer biotechnology"

#6292978

22 December 2020

A medical syringe and a vial are seen in front of Pfizer and BioNTech logos and the EU flag in this creative illustrative photo. The European Medicines Agency (EMA) recommends first COVID-19 coronavirus vaccine developed by the U.S. pharmaceutical corporation Pfizer and German biotechnology company BioNTech for authorisation in the European Union, as global media reported on 21 December, 2020. (Photo illustration by STR/NurPhoto)

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6292946

22 December 2020

A medical syringe and a vial are seen in front of Pfizer and BioNTech logos and the U.S. flag in this creative illustrative photo. The European Medicines Agency (EMA) recommends first COVID-19 coronavirus vaccine developed by the U.S. pharmaceutical corporation Pfizer and German biotechnology company BioNTech for authorisation in the European Union, as global media reported on 21 December, 2020. (Photo illustration by STR/NurPhoto)

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6292966

22 December 2020

A medical syringe and a vial are seen in front of the European Medicines Agency (EMA) logo in this creative illustrative photo. The European Medicines Agency (EMA) recommends first COVID-19 coronavirus vaccine developed by the U.S. pharmaceutical corporation Pfizer and German biotechnology company BioNTech for authorisation in the European Union, as global media reported on 21 December, 2020. (Photo illustration by STR/NurPhoto)

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6292986

22 December 2020

A medical syringe and a vial are seen in front of the European Medicines Agency (EMA) logo and the EU flag in this creative illustrative photo. The European Medicines Agency (EMA) recommends first COVID-19 coronavirus vaccine developed by the U.S. pharmaceutical corporation Pfizer and German biotechnology company BioNTech for authorisation in the European Union, as global media reported on 21 December, 2020. (Photo illustration by STR/NurPhoto)

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6292988

22 December 2020

A medical syringe and a vial are seen in front of the flag of Germany in this creative illustrative photo. The European Medicines Agency (EMA) recommends first COVID-19 coronavirus vaccine developed by the U.S. pharmaceutical corporation Pfizer and German biotechnology company BioNTech for authorisation in the European Union, as global media reported on 21 December, 2020. (Photo illustration by STR/NurPhoto)

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6292990

22 December 2020

A medical syringe and a vial are seen in front of the flag of Germany in this creative illustrative photo. The European Medicines Agency (EMA) recommends first COVID-19 coronavirus vaccine developed by the U.S. pharmaceutical corporation Pfizer and German biotechnology company BioNTech for authorisation in the European Union, as global media reported on 21 December, 2020. (Photo illustration by STR/NurPhoto)

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6292992

22 December 2020

A medical syringe and a vial are seen in front of the flag of Spain in this creative illustrative photo. The European Medicines Agency (EMA) recommends first COVID-19 coronavirus vaccine developed by the U.S. pharmaceutical corporation Pfizer and German biotechnology company BioNTech for authorisation in the European Union, as global media reported on 21 December, 2020. (Photo illustration by STR/NurPhoto)

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6292994

22 December 2020

A medical syringe and a vial are seen in front of the flag of Italy in this creative illustrative photo. The European Medicines Agency (EMA) recommends first COVID-19 coronavirus vaccine developed by the U.S. pharmaceutical corporation Pfizer and German biotechnology company BioNTech for authorisation in the European Union, as global media reported on 21 December, 2020. (Photo illustration by STR/NurPhoto)

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6292996

22 December 2020

A medical syringe and a vial are seen in front of the flag of France in this creative illustrative photo. The European Medicines Agency (EMA) recommends first COVID-19 coronavirus vaccine developed by the U.S. pharmaceutical corporation Pfizer and German biotechnology company BioNTech for authorisation in the European Union, as global media reported on 21 December, 2020. (Photo illustration by STR/NurPhoto)

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6274256

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6274258

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6274260

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6274262

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6274264

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6274266

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6274270

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.